HomeESPR • NASDAQ
Esperion Therapeutics Inc
$2.62
Mar 28, 10:30:27 AM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$2.62
Day range
$2.57 - $2.73
Year range
$0.70 - $3.34
Market cap
484.82M USD
Avg Volume
5.78M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
32.25M71.38%
Operating expense
45.42M88.18%
Net income
-56.34M-1.54%
Net profit margin
-174.7140.75%
Earnings per share
-0.5034.21%
EBITDA
-42.36M0.14%
Effective tax rate
——
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
82.25M-50.71%
Total assets
205.80M-17.00%
Total liabilities
660.79M15.58%
Total equity
-454.99M—
Shares outstanding
185.05M—
Price to book
-0.68—
Return on assets
-49.60%—
Return on capital
-102.10%—
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-56.34M-1.54%
Cash from operations
-37.06M12.75%
Cash from investing
0.00100.00%
Cash from financing
4.47M114.73%
Net change in cash
-32.58M61.49%
Free cash flow
-28.85M17.70%
About
Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan. Wikipedia
Founded
May 1998
Employees
240
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu